Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-13-003528
Filing Date
2013-06-18
Accepted
2013-06-18 17:25:31
Documents
19
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 TO 10-K cmbg_10ka.htm 10-K/A 1594836
2 FORM OF LISTING AGREEMENT cmbg_ex24.htm EX-10.25 35794
3 SECURITIES PURCHASE AGREEMENT cmbg_ex26.htm EX-10.26 64178
4 CONSENT cmbg_ex231.htm EX-23.1 654
5 CERTIFICATION cmbg_ex311.htm EX-31.1 17851
6 CERTIFICATION cmbg_ex312.htm EX-31.2 18029
7 CERTIFICATION cmbg_ex321.htm EX-32.1 9138
8 CERTIFICATION cmbg_ex322.htm EX-32.2 8897
9 img001.jpg GRAPHIC 71687
10 img002.jpg GRAPHIC 2009
11 img003.jpg GRAPHIC 1455
12 img004.jpg GRAPHIC 2753
13 ex231.jpg GRAPHIC 95213
  Complete submission text file 0001354488-13-003528.txt   4263745

Data Files

Seq Description Document Type Size
14 cmbg-20121231.xml EX-101.INS 351732
15 cmbg-20121231.xsd EX-101.SCH 29472
16 cmbg-20121231_cal.xml EX-101.CAL 34872
17 cmbg-20121231_def.xml EX-101.DEF 35430
18 cmbg-20121231_lab.xml EX-101.LAB 177356
19 cmbg-20121231_pre.xml EX-101.PRE 117939
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52282 | Film No.: 13920281
SIC: 6199 Finance Services